JP2024535705A5 - - Google Patents

Info

Publication number
JP2024535705A5
JP2024535705A5 JP2024511968A JP2024511968A JP2024535705A5 JP 2024535705 A5 JP2024535705 A5 JP 2024535705A5 JP 2024511968 A JP2024511968 A JP 2024511968A JP 2024511968 A JP2024511968 A JP 2024511968A JP 2024535705 A5 JP2024535705 A5 JP 2024535705A5
Authority
JP
Japan
Prior art keywords
region
amino acid
heavy chain
acid sequence
complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024511968A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024535705A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/041400 external-priority patent/WO2023028162A1/en
Publication of JP2024535705A publication Critical patent/JP2024535705A/ja
Publication of JP2024535705A5 publication Critical patent/JP2024535705A5/ja
Pending legal-status Critical Current

Links

JP2024511968A 2021-08-25 2022-08-24 免疫抑制性b細胞を標的化する抗体 Pending JP2024535705A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163237065P 2021-08-25 2021-08-25
US63/237,065 2021-08-25
PCT/US2022/041400 WO2023028162A1 (en) 2021-08-25 2022-08-24 Antibodies targeting immunosuppressive b cells

Publications (2)

Publication Number Publication Date
JP2024535705A JP2024535705A (ja) 2024-10-02
JP2024535705A5 true JP2024535705A5 (cg-RX-API-DMAC10.html) 2025-08-29

Family

ID=85322045

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024511968A Pending JP2024535705A (ja) 2021-08-25 2022-08-24 免疫抑制性b細胞を標的化する抗体

Country Status (5)

Country Link
US (1) US20240352156A1 (cg-RX-API-DMAC10.html)
EP (1) EP4392063A4 (cg-RX-API-DMAC10.html)
JP (1) JP2024535705A (cg-RX-API-DMAC10.html)
CN (1) CN118139638A (cg-RX-API-DMAC10.html)
WO (1) WO2023028162A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021173844A1 (en) * 2020-02-26 2021-09-02 Biograph 55, Inc. C19 c38 bispecific antibodies
TW202440636A (zh) * 2023-03-21 2024-10-16 美商傳記55有限公司 Cd19/cd38多特異性抗體
WO2026064774A1 (en) * 2024-09-23 2026-03-26 Biograph 55, Inc. Cd19/cd38 multispecific antibodies for immune checkpoint inhibitor combination therapies

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4860703B2 (ja) * 2005-10-06 2012-01-25 ゼンコー・インコーポレイテッド 最適化された抗cd30抗体
EP3587448B1 (en) * 2013-03-15 2021-05-19 Xencor, Inc. Heterodimeric proteins
KR20200142525A (ko) * 2018-04-05 2020-12-22 노파르티스 아게 암에 대한 삼중특이성 결합 분자 및 이의 용도
UY38701A (es) * 2019-05-21 2020-12-31 Novartis Ag Moléculas de unión a cd19, conjugados, composiciones que las comprenden y usos de las mismas
WO2021173844A1 (en) * 2020-02-26 2021-09-02 Biograph 55, Inc. C19 c38 bispecific antibodies
AU2021373366A1 (en) * 2020-11-06 2023-06-01 Novartis Ag Cd19 binding molecules and uses thereof

Similar Documents

Publication Publication Date Title
JP7853939B2 (ja) 二重特異性チェックポイント阻害剤抗体
US12331119B2 (en) Modified Fc fragment, antibody comprising same, and application thereof
JP2023528350A5 (cg-RX-API-DMAC10.html)
US12180302B2 (en) Heterodimeric antibodies that bind fibroblast activation protein
JP6742245B2 (ja) 多重特異性抗体
CN102448985B (zh) 三或四特异性抗体
JP2019533441A5 (cg-RX-API-DMAC10.html)
JP7835796B2 (ja) 抗体の二量体化を促進するためのヒンジ領域の操作
JP2023506750A5 (cg-RX-API-DMAC10.html)
TWI814715B (zh) Adam9結合分子及使用其的方法
JP2021533169A5 (cg-RX-API-DMAC10.html)
WO2017055539A1 (en) Multispecific antibodies
JP2018517401A5 (cg-RX-API-DMAC10.html)
JP2021533159A5 (cg-RX-API-DMAC10.html)
JP2023516195A5 (cg-RX-API-DMAC10.html)
JP2024535712A5 (cg-RX-API-DMAC10.html)
WO2010112194A1 (en) Antigen-binding polypeptides and multispecific antibodies comprising them
AU2021269130A1 (en) SIRPα and SIRPβ1 antibodies and uses thereof
JP2024540148A5 (cg-RX-API-DMAC10.html)
JP2024526324A5 (cg-RX-API-DMAC10.html)
CN111712521A (zh) Cd38蛋白抗体及其应用
CN110267990A (zh) 结合共刺激性和检查点受体的双特异性免疫调节抗体
JP2023538897A (ja) Fab領域中に非標準的なジスルフィドを有する抗原結合タンパク質
JP2023532248A5 (cg-RX-API-DMAC10.html)
JP2025513714A (ja) Cd3に特異的な脱免疫抗体